首页> 外文OA文献 >Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

【2h】

Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

机译：预防性血小板输血的10×109 / L触发的安全性和成本有效性与传统的20×109 / L触发相比：105例急性髓性白血病患者的前瞻性比较试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hannes Wandt; Markus Frank; Gerhard Ehninger; Christiane Schneider; Norbert Brack; Ali Daoud; Irene Fackler-Schwalbe; Jürgen Fischer; Ringfried Gäckle; Thomas Geer; Peter Harms; Birgit Löffler; Siegfried Öhl; Burkhard Otremba; Monika Raab; Petra Schönrock-Nabulsi; Gerhard Strobel; Rolf Winter; Hartmut Link;
展开▼
作者单位

展开▼
年度 1998
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献

1. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. [J] . Nevo S, Fuller AK, Hartley E, Transfusion: The Journal of the American Association of Blood Banks . 2007,第5期

机译：造血干细胞移植后患者的急性出血并发症，预防性血小板输注触发因素为每升10 x 10（9）和20 x 10（9）。
2. A prospective randomized trial of prophylactic platelet transfusion and bleeding incidence in hematopoietic stem cell transplant recipients: 10,000/L versus 20,000/microL trigger. [J] . Zumberg MS, del Rosario ML, Nejame CF, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2002,第10期

机译：造血干细胞移植受者中预防性血小板输注和出血发生率的前瞻性随机试验：10,000 / L与20,000 / microL触发。
3. A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10 per L versus 30 x 10 per L in allogeneic hematopoietic progenitor cell transplant recipients. [J] . Diedrich B, Remberger M, Shanwell A, Transfusion: The Journal of the American Association of Blood Banks . 2005,第7期

机译：预防性血小板输注触发因素的前瞻性随机试验为每升10 x 10，而同种异体造血祖细胞移植接受者为每升30 x 10。
4. A Phase 1 Trial of CNDO-109-Activated Natural Killer Cells in Patients with High-risk Acute Myeloid Leukemia [O] . Todd A. Fehniger, Jeffrey S. Miller, Robert K. Stuart, -1

机译：高危急性髓系白血病患者中CNDO-109活化的自然杀伤细胞的1期试验
5. Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia [O] . Hannes Wandt, Markus Frank, Gerhard Ehninger, 1998

机译：预防性血小板输血的10×109 / L触发的安全性和成本有效性与传统的20×109 / L触发相比：105例急性髓性白血病患者的前瞻性比较试验

Safety and Cost Effectiveness of a 10 × 109/L Trigger for Prophylactic Platelet Transfusions Compared With the Traditional 20 × 109/L Trigger: A Prospective Comparative Trial in 105 Patients With Acute Myeloid Leukemia

著录项

引文网络

相似文献

相关主题

期刊订阅